Predicta Biosciences logo

Predicta Biosciences Funding & Investors

Boston, MA

Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages.

predictabiosciences.com

Total Amount Raised: $28,600,000

Predicta Biosciences Funding Rounds

  • Series A

    $23,400,000

    Series A Investors

    Engine Ventures
    BrightEdge - American Cancer Society
    Lightchain Capital
    Mass General Brigham Ventures
    Illumina Ventures
    Myeloma Solutions Fund
    CHEER for Dana-Faber

  • Seed

    $5,200,000

    Seed Investors

    Engine Ventures
    Time Partners
    Illumina Ventures
    BrightEdge - American Cancer Society
Funding info provided by Diffbot.